With the growth of China's ophthalmic medical service market and the support of relevant policies, the marketization of ophthalmic chains has gradually blossomed everywhere. It is reported that Aier Ophthalmology (300015), known as "Ophthalmology Moutai", landed in the A** field as early as 2009 and became a leading ophthalmology enterprise in China, thus embarking on the road of expansion and development.
Since its launch in Changsha in 2002, Aier Ophthalmology has been adhering to the bright mission of "enabling all people, regardless of poverty or wealth, to enjoy the right to eye health", actively fulfilling its corporate citizenship obligations, innovating the "cross-subsidy" public welfare model, relying on the "hierarchical diagnosis and treatment" and the same city network model, continuously expanding the layout of medical services, helping Guangming to help from various aspects such as funds, technology, talents, and mechanisms, promoting the sinking of high-quality medical resources, and providing timely and effective eye health services for people in need.
Under the leadership of Chairman Chen Bang, Aier Ophthalmology also actively explores new models of Sino-foreign cooperation, with the help of overseas high-quality resources, the first joint specialized disease clinic, the launch of differentiated products and services, and the creation of a regional-level characteristic eye disease center. This initiative not only improves the quality and efficiency of medical services, but also provides patients with a more personalized program.
It is understood that since the first step of internationalization officially started in 2016, Aier Ophthalmology's internationalization road has gone through 7 years, through the acquisition of foreign ophthalmic chain institutions, the company has become an ophthalmic chain medical group with 3 listed companies in Chinese mainland, Europe and Southeast Asia. As of June 30, 2023, there are 842 Aier Eye Hospitals, Eye Centers and Clinics worldwide. Among them, there are 124 ophthalmology centres and clinics overseas. The continuous expansion of Aier Ophthalmology's overseas layout not only brings a global medical service network, but more importantly, realizes the synchronization of global advanced technology, and brings light to more patients through "sharing global ophthalmology wisdom".
In addition, Aier Ophthalmology also actively participates in international academic exchange activities and explores cutting-edge technologies with world ophthalmology experts. They have released a series of reports covering million-level surgical big data, including "Central European Refractive Cataract Surgery***Central European Myopia Surgery*** Report", etc. These academic collaborations have further enhanced the influence of Chinese ophthalmologists in the world.
With its outstanding performance in the field of ophthalmic medicine, not long ago, Aier Ophthalmology won the title of "Advanced Collective of New Hunan Contribution Award"; Chen Bang, chairman of Aier Ophthalmology Group, was awarded the title of "Advanced Individual of New Hunan Contribution Award". This is after winning the first "New Hunan Contribution Award Advanced Collective", Aier Ophthalmology has been affirmed again. At the same time, Aier Eye Hospital Group was once again selected into the "2023 Sanxiang Top 100 Private Enterprises List", and its corporate strength was further affirmed.
From the bank of the Xiangjiang River to the other side of the ocean, from Changsha to the global layout, Aier Ophthalmology has always been committed to allowing people to enjoy high-quality and accessible ophthalmic medical services at their doorstep, and the company's development achievements are remarkable. As one of the well-known enterprises in Hunan Province, Aier Ophthalmology will continue to adhere to the development concept of "sharing global ophthalmic wisdom", continuously improve its medical service capabilities and technical level, and strive to become one of the most trusted ophthalmic medical institutions in the eyes of the people.